BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9111058)

  • 1. Target-dependent effect of phosphorylation on the DNA binding activity of the TAL1/SCL oncoprotein.
    Prasad KS; Brandt SJ
    J Biol Chem; 1997 Apr; 272(17):11457-62. PubMed ID: 9111058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
    Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
    J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1.
    Cheng JT; Cobb MH; Baer R
    Mol Cell Biol; 1993 Feb; 13(2):801-8. PubMed ID: 8423803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
    Huang S; Qiu Y; Stein RW; Brandt SJ
    Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts.
    Tang T; Prasad KS; Koury MJ; Brandt SJ
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):615-20. PubMed ID: 10527940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced turnover of the TAL1/SCL transcription factor in endothelial cells.
    Tang T; Arbiser JL; Brandt SJ
    J Biol Chem; 2002 May; 277(21):18365-72. PubMed ID: 11904294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
    Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
    Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tal1/SCL binding to pericentromeric DNA represses transcription.
    Wen J; Huang S; Pack SD; Yu X; Brandt SJ; Noguchi CT
    J Biol Chem; 2005 Apr; 280(13):12956-66. PubMed ID: 15677454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation.
    Nielsen AL; Norby PL; Pedersen FS; Jorgensen P
    J Biol Chem; 1996 Dec; 271(49):31463-9. PubMed ID: 8940159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence determinants of DNA binding by the hematopoietic helix-loop-helix transcription factor TAL1: importance of sequences flanking the E-box core.
    Gould KA; Bresnick EH
    Gene Expr; 1998; 7(2):87-101. PubMed ID: 9699481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity.
    Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
    Cancer Res; 2005 Jun; 65(11):4515-9. PubMed ID: 15930267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor.
    Huang S; Brandt SJ
    Mol Cell Biol; 2000 Mar; 20(6):2248-59. PubMed ID: 10688671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
    Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
    Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain.
    Wadman IA; Hsu HL; Cobb MH; Baer R
    Oncogene; 1994 Dec; 9(12):3713-6. PubMed ID: 7970731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
    Hansson A; Manetopoulos C; Jönsson JI; Axelson H
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
    Hofmann TJ; Cole MD
    Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
    Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
    Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
    Xia Y; Hwang LY; Cobb MH; Baer R
    Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
    Cheng JT; Hsu HL; Hwang LY; Baer R
    Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase-A dependent phosphorylation of transcription enhancer factor-1 represses its DNA-binding activity but enhances its gene activation ability.
    Gupta MP; Kogut P; Gupta M
    Nucleic Acids Res; 2000 Aug; 28(16):3168-77. PubMed ID: 10931933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.